UK markets close in 1 hour 30 minutes
FTSE 250
19,568.25 -151.12 (-0.77%) AIM
752.50 -2.19 (-0.29%) GBP/EUR
1.1653 +0.0009 (+0.07%) GBP/USD
1.2473 +0.0011 (+0.08%) Bitcoin GBP
50,872.79 -2,041.88 (-3.86%) CMC Crypto 200
1,373.59 -8.98 (-0.65%)
OPKO Health, Inc. (OPK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:00AM EDT. Market open.
| Previous close | 1.2300 |
| Open | 1.2000 |
| Bid | 1.1900 x 1600 |
| Ask | 1.2100 x 100 |
| Day's range | 1.2000 - 1.2300 |
| 52-week range | 0.8500 - 2.2400 |
| Volume | |
| Avg. volume | 9,128,137 |
| Market cap | 840.363M |
| Beta (5Y monthly) | 1.84 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
OPKO Health (OPK) expects to re-establish profitability in its clinical laboratory business via its latest efforts to streamline its laboratory services business.
- Zacks
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
The recent deal will augment Labcorp's (LH) laboratory services network and expand access to the company's high-quality clinical laboratory services.
- Zacks
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
© 2024 Yahoo. All rights reserved.